This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
EAU 2018
EAU 2018 Bladder Cancer
Conferences
EAU 2018
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testis and Penile Cancer
Endourology
Press
AUA 2018
Viewing 341-360 of 364 articles
AUA 2018: Early versus Standard Catheter Removal After Complete Anatomical Reconstruction During Robot-Assisted Radical Prostatectomy: Results from RIPRECA
AUA 2018: Surgical Techniques: Tips & Tricks: Robotic Partial Nephrectomy
AUA 2018: Tumor Board - Kidney Cancer: The Current State of Knowledge and Management Paradigms for Patients with Kidney Cancer
AUA 2018: Clinical and Oncological Outcomes of Robot-Assisted Radical Prostatectomy with Nerve Sparing for High-Risk Prostate Cancer Patients
AUA 2018: Duration of PSA Surveillance after Radical Prostatectomy: A Risk Adapted Approach
AUA 2018: Should Gleason Score at the Positive Surgical Margin appear on the Pathology Report for Robot-Assisted Radical Prostatectomy?
AUA 2018: Predicting Perioperative Complications in Patients Receiving Radical Cystectomy Using Pre-Operative CT-Measured Adipose Tissue Indices
AUA 2018: Application of AUA Risk Stratification for NMIBC: Long-term Results in a Contemporary Single Institution Cohort
AUA 2018: Adverse Events Reported With Da Vinci Surgical Systems Over the Last Decade
AUA 2018: Establishment of the Optimal Follow-Up Schedule After Radical Prostatectomy
AUA 2018: Evaluation of the Risks and Benefits of CT Urography for Assessment of Gross Hematuria
AUA 2018: Environmental Impact on Urologic Health
AUA 2018: Predictors of Pheochromocytoma Surgery Outcomes Using a Pre-Operative Severity Classification Scale
AUA 2018: Changes in Brain Activity Following Intradetrusor Injection of OnabotulinumtoxinA in Patients with Multiple Sclerosis: an fMRI Study
AUA 2018: Urology’s Approach to Pain Management in an Opioid Epidemic
AUA 2018: Adrenalectomy: Shouldn’t Urologists Be Doing More?
AUA 2018: Long Term Outcomes for Patients with Von Hippel Lindau and Pheochromocytoma: Defining the Best Candidates for Active Surveillance
AUA 2018: Is Prostate Cancer Screening and Risk Stratification Moving Beyond the PSA Test?
AUA 2018: Cleveland Clinic-led Study Finds that More than 40 Percent of Prostate Biopsies Could Have Been Avoided with New Blood Test
AUA 2018: Primary Adrenal Malignancy: Insights into the Epidemiology of a Rare Histological Subset
10
11
12
13
14
15
16
17
18
19
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free